Innoviva, Inc. - 10%+ Owner at Entasis Therapeutics Holdings Inc.

Issuer-level insider activity

Role
10%+ Owner
Issuer ticker
ETTX
Identity Names, identifiers, and filing context for this profile. 1 identity field
Entity type
Company
Source evidence Original filing metadata and source links for verification. 1 source field
Source filing history
Open source filing history

No buys or sells have been reported by Innoviva, Inc. since 12 Aug 2025

Reported holdings for Innoviva, Inc. in Entasis Therapeutics Holdings Inc.

Form 4 holding 10%+ Owner

Entasis Therapeutics Holdings Inc.

Security class
Warrants to Purchase Common Stock
Shares / value
18,672,897
Estimated value
$37,345,794
Report date
08 Jul 2022
Price
$2.00
Ownership
Direct
Underlying class
Common Stock
Underlying amount
Form 4 holding 10%+ Owner

Entasis Therapeutics Holdings Inc.

Security class
Warrants to Purchase Common Stock
Shares / value
10,000,000
Estimated value
$20,000,000
Report date
08 Jul 2022
Price
$2.00
Ownership
Indirect
Underlying class
Common Stock
Underlying amount
Form 4 holding 10%+ Owner

Entasis Therapeutics Holdings Inc.

Security class
Convertible Promissory Note
Shares / value
0
Estimated value
Report date
08 Jul 2022
Price
Ownership
Indirect
Underlying class
Common Stock
Underlying amount

Transaction history for Innoviva, Inc. in Entasis Therapeutics Holdings Inc.

Sym Class Transaction % SEC-reported value SEC-reported price Shares Shares after Date Ownership
* marks a reported price that did not pass the local price check.
We use cookies and similar technologies to provide certain features, enhance the user experience and, if you allow them, measure engagement and deliver advertising. Analytics and marketing storage stay off until you grant consent. By clicking on "Agree and continue", you declare your consent to the use of the selected optional cookies. Manage preferences to update or revoke optional consent for future visits. For more information, see our Privacy Policy .